Biogen (BIIB) Amortization - Intangibles (2009 - 2026)

Biogen's Amortization - Intangibles history runs 18 years deep, the most recent figure standing at $136.5 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles rose 22.09% year-over-year to $136.5 million; the TTM figure through Mar 2026 stood at $539.7 million (up 12.39% YoY), while the FY2025 annual figure was $515.0 million, up 15.29% from the prior year.
• Amortization - Intangibles was $136.5 million for Q1 2026 at Biogen, roughly flat from $136.6 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $175.0 million in Q4 2022 to a low of $50.2 million in Q1 2023.
• Historically, Amortization - Intangibles has averaged $100.3 million across 5 years, with a median of $86.9 million in 2024.
• Biggest YoY gain for Amortization - Intangibles was 156.98% in 2022; the steepest drop was 88.83% in 2022.
• A 5-year view of Amortization - Intangibles shows it stood at $175.0 million in 2022, then slumped by 56.23% to $76.6 million in 2023, then soared by 97.39% to $151.2 million in 2024, then slipped by 9.66% to $136.6 million in 2025, then declined by 0.07% to $136.5 million in 2026.
• The last three Amortization - Intangibles figures came in at $136.5 million (Q1 2026), $136.6 million (Q4 2025), and $135.7 million (Q3 2025), per Business Quant data.